Nanosphere Inc. develops manufactures and markets an advanced molecular diagnostics platform the Verigene System which enables simple low cost and highly sensitive genomic and protein testing on a single platform.


Updates from The Motley Fool

Latest updates on Nanosphere from Fool.com.


Stock Performance

NSPH vs. S&P 500 | 2 Year Performance
View Interactive NSPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Nanosphere.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0.00
P/E (ttm): 0.00
EPS (ttm): -$5.28
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Nanosphere.
CAPS Rating 1 out of 5
 
137 Outperform
42 Underperform
CAPS All Stars
 
24 Outperform
28 Underperform

How do you think Nanosphere will perform against the market?



You pick for Nanosphere is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael McGarrity, CEO

31% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Nanosphere.

Nanosphere Inc. develops manufactures and markets an advanced molecular diagnostics platform the Verigene System which enables simple low cost and highly sensitive genomic and protein testing on a single platform.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT